PTH and type 2 diabetes mellitus: Interestingly, a reduction in pre-osteoblast beta-oxidation capacity leads to decreased parathyroid hormone (PTH) sensitivity [126], a potential contributor to the elevated levels of PTH seen in HI/T2DM/CVD patients [127,128].